Welcoming Camp Summit: Canada’s first summer camp for children with alopecia areata!
CANAAF is proud to announce a new Ontario summer camp for children with alopecia areata in partnership with Camp Maple Leaf. Learn more.
Exciting news! Olumiant (baricitinib) has finally been approved as a treatment for Alopecia Areata!
On June 13th, a JAK inhibitor called Olumiant became the first FDA-approved treatment for alopecia areata. Read more and find out what this means for Canadians.
Red Table Talk: The Devastating Impact of Alopecia
On the latest episode of Red Table Talk, Jada Pinkett Smith highlights the devastating impact that alopecia has on a person and their family. Link to episode within.
CoNCERT Pharmaceuticals Reports Positive Topline Results for First CTP-543 Phase 3 Clinical Trial in Alopecia Areata
CoNCERT Pharmaceuticals' latest press release shows exciting potential for CTP-543 to be a best-in-class treatment for alopecia areata.
International Clinical Trials Day 2022: What it’s like to be in a clinical trial
Today is International Clinical Trials Day! David sheds some light on his journey with alopecia universalis and what it's like to participate in a clinical trial to aid in the development of a new treatment for alopecia areata.
“What I Learned From Losing My Hair”: Alopecia Spotlight on Chatelaine.com
Read about the hair loss stories of five women in Chatelaine's latest issue as they share highs and lows on the road to acceptance.